Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder
Keywords
Opioid use disorder
Medications for opioid use disorder
Buprenorphine
Structural stigma
Regulations
Barriers to care
Cited by (0)
© 2020 Elsevier Inc. All rights reserved.